Find, compare & contact
Rivaroxaban API Manufacturers
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Producer
Produced in:
Established in: 1951
MOQ: -
Employees: 455+
Largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market.
FDA approved european manufcaturing facilities
Export APIs to more than 60 countries worldwide
+ 0
All certificates
Producer
Produced in:
Established in: 1984
MOQ: -
Employees: 2000+
Vertically integrated company
Largest producer of Montelukast in the world
USFDA & WHO GMP approved API plants
+ 0
All certificates
Distributor
Produced in:
Established in: 1987
MOQ: 1 kg
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 37 years
+ 0
All certificates
Producer
Produced in:
Established in: 1978
MOQ: -
Employees: 10k+
199 API-Related Granted Patents
Global Presence in 50+ Markets
Advanced technology and R&D Capabilities
+ 0
All certificates
Producer
Produced in:
Established in: 2022
MOQ: -
Employees: 100+
Operating on GMP guidelines with the most recent technologies and equipment
High-quality products at unrivaled prices
Specialize in Narcotic and Non-Narcotic APIs
+ 0
All certificates
Producer
Produced in:
Established in: 2019
MOQ: 1 kg
Employees: 10+
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
+ 0
All certificates
Producer
Produced in:
Established in: 1993
MOQ: 10 kg
Employees: 600
We can develop new APIs upon request
GMP, EMA/FDA, OSHAS cert. CDMO
12 local offices, strategically around the world
+ 0
All certificates
Distributor
Produced in:
Established in: 1997
MOQ: -
Employees: 50
GMP and GDP certified
Biotechnological research leadership and manufacturer
Extensive distribution network for product global accessibility
+ 0
All certificates
Producer
Produced in:
Established in: 2005
MOQ: -
Employees: 500
Platinum drugs rank Top 3 in the Chinese market
Dedicated to producing anti-cancer, anti-tumor, anti-fungal, and other APIs and Intermediates
Plants with GMP standard
+ 0
All certificates
Distributor
Produced in:
Established in: 2019
MOQ: -
Employees: 50+
ISO 9001, SGS, Certificated supplier.
Audit available either on site or remote.
Professional One Stop Service for delivery to customers.
+ 0
All certificates
Producer
Produced in:
Established in: 2021
MOQ: -
Employees: 19
API, Intermediates, Building Blocks, Impurities, Amino acids and Peptides
Small quantity APIs to commercial scale
GMP and USFDA certification based on quantity, order, assignment.
+ 0
All certificates
Distributor
Produced in:
Established in: 1994
MOQ: -
Employees: 50+
26+ years of distribution expertise with regulatory excellence
16 worldwide locations supplying high quality ingredients
All our manufacturer partners are cGMP complaint
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 1994
MOQ: -
Employees: 4,000
All our 5 plants are top notch and FDA approved
We are a backwards integrated company
We have received 24 CEP’s and 27 USDMF’s
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Distributor
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 1984
MOQ: -
Employees: 21,650
Diverse portfolio of 180+APIs
1754+ DMF across global markets
1100+ patents filed, and more than 70 own patents granted
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Distributor
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Rivaroxaban API 366789-02-8?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Rivaroxaban. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Rivaroxaban
- Synonyms:
- Xarelto
- Cas Number:
- 366789-02-8
- DrugBank number:
- DB06228
- Unique Ingredient Identifier:
- 9NDF7JZ4M3
About Rivaroxaban
What makes Rivaroxaban unique? Rivaroxaban is an anticoagulant and the first orally active direct factor Xa inhibitor. Unlike warfarin, routine lab monitoring of INR is not necessary. However there is no antidote available in the event of a major bleed. Only the 10 mg tablet can be taken without regard to food. The 15 mg and 20 mg tablet should be taken with food. FDA approved on July 2011.
Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements
Rivaroxaban is a type of Antithrombotics
Antithrombotics, a subcategory of pharmaceutical active pharmaceutical ingredients (APIs), play a crucial role in preventing and treating thrombotic disorders, which are characterized by the formation of blood clots within blood vessels. These medications are essential in reducing the risk of thrombosis, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke, which can lead to severe health complications.
Antithrombotics exert their therapeutic effects through various mechanisms. One commonly used class of antithrombotics is anticoagulants, which inhibit the clotting process by interfering with the formation of blood clots. These drugs include heparin, warfarin, and direct oral anticoagulants (DOACs). They are administered to patients with conditions like atrial fibrillation, venous thromboembolism, or mechanical heart valves to prevent clot formation.
Another class of antithrombotics is antiplatelet agents, which prevent platelet aggregation, an essential step in blood clot formation. Aspirin, clopidogrel, and ticagrelor are well-known antiplatelet drugs used to prevent thrombosis in patients with coronary artery disease, ischemic stroke, or peripheral artery disease.
Antithrombotics are typically prescribed based on the individual patient's risk factors, medical history, and the specific thrombotic condition being treated. Dosage and administration instructions may vary depending on the drug's pharmacokinetic profile and desired therapeutic outcomes.
As with any medication, antithrombotics may have potential side effects, such as increased bleeding risk. Therefore, healthcare professionals carefully assess the patient's overall health status, including any underlying conditions, before prescribing these medications.
In conclusion, antithrombotics are a crucial subcategory of pharmaceutical APIs that play a vital role in preventing and treating thrombotic disorders. By inhibiting clot formation through various mechanisms, these medications significantly contribute to reducing the risk of serious complications associated with blood clots.
Rivaroxaban (Antithrombotics), classified under Anticoagulants
Anticoagulants are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to prevent and treat blood clotting disorders. These medications play a crucial role in various medical conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF). Anticoagulants work by inhibiting the formation of blood clots or by preventing existing clots from getting larger.
There are different types of anticoagulants available, including direct thrombin inhibitors, vitamin K antagonists, and factor Xa inhibitors. Direct thrombin inhibitors, such as dabigatran, directly target the enzyme thrombin to hinder clot formation. Vitamin K antagonists, like warfarin, interfere with the production of clotting factors that rely on vitamin K. Factor Xa inhibitors, such as rivaroxaban and apixaban, inhibit the activity of factor Xa, a crucial component in the clotting cascade.
Anticoagulants are commonly prescribed to patients at risk of developing blood clots or those with existing clotting disorders. They are often used during surgeries, such as hip or knee replacements, to minimize the risk of post-operative clot formation. Patients with AF, a condition characterized by irregular heart rhythm, may also be prescribed anticoagulants to prevent stroke caused by blood clots.
While anticoagulants offer significant benefits in preventing and treating clot-related conditions, they also carry potential risks, including bleeding complications. Patients taking anticoagulants require careful monitoring to ensure the right dosage is administered, as excessive anticoagulation can lead to hemorrhage. Regular blood tests and close medical supervision are essential to manage the delicate balance between preventing clots and avoiding excessive bleeding.
In conclusion, anticoagulants are a crucial category of pharmaceutical APIs used to prevent and treat blood clotting disorders. They function by inhibiting clot formation or preventing existing clots from enlarging. While highly beneficial, their use requires careful monitoring to minimize the risk of bleeding complications.
Rivaroxaban manufacturers | traders | suppliers
We have 44 companies offering Rivaroxaban produced in 12 different countries.
Get in contact with the supplier of your choice:
- Polpharma from Poland, product country of origin Poland
- Morepen Laboratories Ltd. from India, product country of origin India
- Sinoway industrial Co.,Ltd from China, product country of origin China
- Jubilant Pharmova from India, product country of origin India
- PluviaEndo from Turkey, product country of origin Turkey
- Apino Pharma Co., Ltd. from China, product country of origin China
- Suanfarma from Spain, product country of origin Spain
- AXXO GmbH from Germany, product country of origin World
- Shandong Boyuan from China, product country of origin China
- Aurora Industry Co., Ltd from China, product country of origin China
- SETV Global from India, product country of origin India
- Rochem International, Inc. from United States, product country of origin United States
- Zhejiang Charioteer from China, product country of origin China
- Zhejiang Supor from China, product country of origin China
- Vasudha Pharma Chem Ltd. from India, product country of origin India
- Amino Chemicals from Malta, product country of origin Malta
- Srini Pharma from India, product country of origin India
- Weijie Pharmaceuticals from China, product country of origin China
- Gedeon Richter from Hungary, product country of origin Hungary
- Raks Pharma from India, product country of origin India
- HEC Pharm from Germany, product country of origin Unknown
- KRKA from Slovenia, product country of origin Slovenia
- Intas Pharma from United Kingdom, product country of origin Unknown
- Quimica Sintetica from Spain, product country of origin Spain
- Flavine from Germany, product country of origin Unknown
- Zhejiang Changming from China, product country of origin China
- Cambrex from Italy, product country of origin United States
- Dr. Reddy's from India, product country of origin India
- Symed Labs from India, product country of origin India
- Kinsy from Spain, product country of origin Spain
- Unichem Labs. from India, product country of origin India
- Menovo from China, product country of origin China
- Qilu Antibiotics from China, product country of origin China
- Shaoxing Hantai Pharma from China, product country of origin China
- Farmak from Czech Republic, product country of origin Czech Republic
- Moehs from Spain, product country of origin Spain
- Optimus Drugs Pvt Ltd from India, product country of origin India
- ZCL Chemicals from India, product country of origin India
- Micro Labs from India, product country of origin India
- Bayer from Germany, product country of origin Unknown
- Medichem from Spain, product country of origin Malta
- MSN Labs. from India, product country of origin India
- Lupin from India, product country of origin India
- Piramal Pharma Solutions from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.